DocGo Inc. provided earnings guidance for the year 2024. The revenue expectation for 2024 base businesses going forward, medical transportation and non-migrant mobile health is $280 million to $300 million, in line with previous expectations.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.185 USD | +5.12% | +7.46% | -43.29% |
May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
May. 09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.29% | 308M | |
0.00% | 1.98B | |
+24.73% | 1.85B | |
+64.66% | 716M | |
-11.16% | 462M | |
-14.18% | 181M | |
-15.75% | 132M | |
+1.92% | 67.85M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Provides Earnings Guidance for the Year 2024